Allergan (AGN)
News
| May 25 | Updated. Putting in some good work around the $90 level. STO x^ potential. Fab 5 cand. $AGN http://chart.ly/xbxaa7i by 1nvestor |
| May 21 | I got luggage to take my clothes to college RT @ivanhoff One of this year's most wanted graduation gifts is breast enhancement surgery. $AGN by RipleyFan |
| May 21 | Remember I got a Cross pen RT @ivanhoff One of this year's most wanted graduation gifts is breast enhancement surgery. $AGN by harmongreg |
| May 21 | One of this year's most wanted graduation gifts is breast enhancement surgery. $AGN by ivanhoff |
| May 21 | Ex-Dividend Stocks http://stks.co/3ui0 My story via @TheStreet $TRI $AGN $HPY $INFY #ExDividend #Dividend by azendrian |
| May 18 | Cash Dividend On The Way From Allergan |
| May 18 | selling $AAPL to buy $FB is like working extra shifts @ $MCD to pay for that $AGN botox treat. And U sez the stk god has no humor! by wboscoho |
| May 18 | $AGN AEGON lagging the other financials today #aegon #euronext by dvk1970 |
| May 17 | $SPY and $AGN by ksnyder2000 |
| May 16 | NICE Rec for Allergan's Botox |
| May 14 | S&P 500 Analyst Estimate Revisions for May 14 |
| May 14 | UK regulator rapped over breast implant scandal |
| May 11 | L’Oreal, Oracle-Google, Optus, Nokia: Intellectual Property |
Profile
Exchange: NYSE Sector: Healthcare Industry: Drug Manufacturers - Other
Allergan, Inc., is a global specialty pharmaceutical company. Their product ranges include ophthalmic pharmaceuticals, dermatology products, and neurological products. The company's most notable neurologic product is Botox, used around the world to treat a variety of debilitating disorders associated with muscle overactivity and also well-knownâunder the trade names Botox Cosmetic and Vistabelâ for the treatment of facial lines.
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Allergan is up 9.84% over the last year vs S&P 500 Total Return up 1.62%, Forest Laboratories down 6.71%, and MAP Pharmaceuticals down 28.53%.
- AGN Total Returns
- ^SPXTR Total Returns
- FRX Total Returns
- MAPP Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these AGN related companies
Pro Strategies Featuring AGN
Did Allergan make it into our Pro Portfolio Strategies?
AGN Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other AGN Resources
- Company Website
- Wiki Page
- Investor Relations
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| AGN | 90.53 | +0.04 | +0.04% | 27.59B |
| AGMA | 18.51 | +0.00 | +0.00% | |
| AGM | 24.44 | +0.11 | +0.45% | 253.20M |
| AGII | 28.82 | +0.77 | +2.75% | 753.64M |
| AGG | 110.92 | +0.17 | +0.15% | |
| AGEND | 5.20 | +0.06 | +1.17% | |
| AGEN | 5.20 | +0.06 | +1.17% | 116.95M |
| AFCE | 21.69 | +0.84 | +4.03% | 528.80M |
| AFB | 15.39 | +0.04 | +0.26% | |
| AFAM | 21.88 | +0.97 | +4.64% | 205.02M |
